{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:03:23Z","timestamp":1789686203068,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:p>\n            Familial combined hyperlipidemia (FCH) is characterized by a variable expression of hypercholesterolemia and\/or hypertriglyceridemia. We evaluated the variability in lipid phenotype expression over a 5-year period and studied factors affecting the lipid phenotype expression. A total of 32 families (299 subjects) were studied in 1994 and in 1999. Subjects were classified as having FCH when total cholesterol and\/or triglyceride levels exceeded the 90th percentile adjusted for age and sex. In 1994, 93 (31%) of the 299 subjects were affected, whereas 206 (69%) of the subjects were unaffected relatives. In 1999, a diagnosis of FCH was consistent in 69 (74%) of the 93 subjects. So, 26% of the FCH subjects in 1994 showed a sporadic normolipidemic pattern (ie, total cholesterol and\/or triglycerides &lt;90th percentile) in 1999. Among the 206 unaffected relatives in 1994, 178 (86%) remained unaffected in 1999, and 28 (14%) developed an FCH lipid phenotype. Multiple regression analysis showed that sex (odds ratio 2.03, 95% CI 1.09 to 3.87;\n            <jats:italic>P<\/jats:italic>\n            =0.03) and body mass index (odds ratio 1.14, 95% CI 1.05 to 1.24;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01) significantly contributed to the variability in lipid phenotype expression. Thus, a diagnosis of FCH, based on plasma total cholesterol and\/or triglyceride levels, is consistent in only 74% of the subjects over a 5-year period. Two other major characteristics of our FCH group, compared with the unaffected relatives, included elevated apolipoprotein B (apoB) levels and the presence of small dense low density lipoprotein (LDL), as reflected by a low value of the parameter\n            <jats:italic>K<\/jats:italic>\n            (apoB 1461\u00b1305 versus 997\u00b1249 mg\/L, respectively [\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001];\n            <jats:italic>K<\/jats:italic>\n            value \u22120.22\u00b10.19 versus \u22120.02\u00b10.19, respectively [\n            <jats:italic>P<\/jats:italic>\n            &lt;0.001]). We now report that the apoB concentration and the\n            <jats:italic>K<\/jats:italic>\n            value show less variability in time and are more consistently associated with FCH, inasmuch as affected FCH subjects, compared with the unaffected relatives, persistently show a higher apoB level and a lower value of parameter\n            <jats:italic>K<\/jats:italic>\n            , reflecting small dense LDL, even when they present a sporadic normolipidemic pattern. In conclusion, our results emphasize the need for reevaluation of the diagnostic criteria for FCH. We demonstrate that apoB and small dense LDL are attractive new candidates for defining FCH. Further studies are indicated to evaluate the role of apoB and small dense LDL as diagnostic criteria for FCH.\n          <\/jats:p>","DOI":"10.1161\/hq0202.104059","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T23:16:47Z","timestamp":1027898207000},"page":"274-282","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":120,"title":["Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families"],"prefix":"10.1161","volume":"22","author":[{"given":"Mario J.","family":"Veerkamp","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Division of General Internal Medicine, and the Department of Epidemiology and Biostatistics (J.C.M.H.), University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"de Graaf","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of General Internal Medicine, and the Department of Epidemiology and Biostatistics (J.C.M.H.), University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J.H.","family":"Bredie","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of General Internal Medicine, and the Department of Epidemiology and Biostatistics (J.C.M.H.), University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.M.","family":"Hendriks","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of General Internal Medicine, and the Department of Epidemiology and Biostatistics (J.C.M.H.), University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre N.M.","family":"Demacker","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of General Internal Medicine, and the Department of Epidemiology and Biostatistics (J.C.M.H.), University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton F.H.","family":"Stalenhoef","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Division of General Internal Medicine, and the Department of Epidemiology and Biostatistics (J.C.M.H.), University Medical Center Nijmegen, Nijmegen, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107332"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(76)90089-5"},{"key":"e_1_3_3_3_2","first-page":"812","volume":"58","year":"1996","unstructured":"Bredie SJ, Kiemeney LA, de Haan AF, Demacker PN, Stalenhoef AF. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet. 1996; 58: 812\u2013822.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1997.1850734.x"},{"key":"e_1_3_3_5_2","first-page":"203","volume":"7","year":"1987","unstructured":"Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis. 1987; 7: 203\u2013207.","journal-title":"Arteriosclerosis"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.13.3.8443147"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.15.4.452"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb00004.x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.13.7.8318511"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.6.4.387"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1994.tb01059.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-199806000-00002"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.82.2.2372896"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.9.3.335"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.1.604"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.14.8.8049184"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.17.5.834"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.14.11.7947591"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/301962"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(96)05924-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90550-I"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/26.13.1775"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/26.8.1205"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00432-9"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38613-2"},{"key":"e_1_3_3_26_2","first-page":"1295","volume":"51","year":"1992","unstructured":"de Graaf J, Swinkels DW, de Haan AFJ, Demacker PNM, Stalenhoef AFH. Both inherited susceptibility and environmental exposure determine the low density lipoprotein subfraction pattern distribution in healthy Dutch families. Am J Hum Genet. 1992; 51: 1295\u20131310.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00381-6"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(97)00134-2"},{"key":"e_1_3_3_29_2","unstructured":"Smit HA Verschuren WMM Bueno de Mesquita HB. Monitoring of risk factors and health in the Netherlands (Morgen-Project). Bilthoven The Netherlands: RIVM (National Institute of Public Health and the Environment); 1994. Report 263200001 (www.RIVM.nl)."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/302490"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0498-369"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2000.570105.x"},{"key":"e_1_3_3_33_2","first-page":"304","volume":"9","year":"1999","unstructured":"Gaddi A, Galetti C, Pauciullo P, Arca M. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice; committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group. Nutr Metab Cardiovasc Dis. 1999; 9: 304\u2013311.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"e_1_3_3_34_2","first-page":"246","volume":"51","year":"1993","unstructured":"Schaefer EJ. New recommendations for the diagnosis and treatment of plasma lipid abnormalities. Nutr Rev. 1993; 51: 246\u2013253.","journal-title":"Nutr Rev"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/hq0202.104059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:30:54Z","timestamp":1715653854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/hq0202.104059"}},"subtitle":["Results of a 5-Year Follow-Up Study"],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1161\/hq0202.104059"],"URL":"https:\/\/doi.org\/10.1161\/hq0202.104059","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"2002-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}